Verana Health, Inc.
Big Data
Verana Health leverages advanced AI and machine learning technologies to transform real-world clinical data into actionable insights, aiming to improve patient care. Partnering with leading medical societies, Verana Health provides comprehensive data solutions for ophthalmology, neurology, and urology, supporting clinical research and healthcare advancements.
Founded: 2018
Sujay Jadhav Chief Executive Officer |
Andrea Sim Chief Product Officer |
Lawrence Whittle President |
Chris Reiling Chief Revenue Officer |
Ashish Gupta Chief Financial Officer |
Kirk Fjeldheim Chief Information Security Officer |
Jennifer Farris Chief People Officer |
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Zhongdi Chu, PhD, MSc, discusses Verana Health’s research into geographic atrophy.
Verana Health announced the development of Qdata® Geographic Atrophy at ARVO 2023, the annual conference of the Association for Research in Vision and Ophthalmology.
Verana Health announced the availability of its first market tracking Data as a Service (DaaS) product, which provides accurate and timely data and insights into product performance and market dynamics with direct data access.
Verana Health and the American Academy of Ophthalmology have announced the Verana Research Network, an IRIS Registry (Intelligent Research in Sight) initiative intended to help advance data-driven clinical research and care. The network consists of academic medical centers (AMCs) and ophthalmology practices joining together to utilize IRIS Registry data and Verana Health capabilities to help improve patients' access to, and streamline health care providers' execution of clinical trials.
Verana Health is developing a neurology module for MS research with de-identified and curated real-world data from more than 30,000 patients.